{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:48:24Z","timestamp":1792014504558,"version":"4.4.0"},"reference-count":122,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>To highlight recent advances in pediatric cholestatic liver disease, including promising novel prognostic markers and new therapies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Findings<\/jats:title>\n            <jats:p>Additional genetic variants associated with the progressive familial intrahepatic cholestasis (PFIC) phenotype and new genetic cholangiopathies, with an emerging role of ciliopathy genes, are increasingly being identified. Genotype severity predicts outcomes in bile salt export pump (BSEP) deficiency, and post-biliary diversion serum bile acid levels significantly affect native liver survival in BSEP and progressive familial intrahepatic cholestasis type 1 (FIC1 deficiency) patients. Heterozygous variants in the MDR3 gene have been associated with various cholestatic liver disease phenotypes in adults. Ileal bile acid transporter (IBAT) inhibitors, approved for pruritus in PFIC and Alagille Syndrome (ALGS), have been associated with improved long-term quality of life and event-free survival.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Next-generation sequencing (NGS) technologies have revolutionized diagnostic approaches, while discovery of new intracellular signaling pathways show promise in identifying therapeutic targets and personalized strategies. Bile acids may play a significant role in hepatic damage progression, suggesting their monitoring could guide cholestatic liver disease management. IBAT inhibitors should be incorporated early into routine management algorithms for pruritus. Data are emerging as to whether IBAT inhibitors are impacting disease biology and modifying the natural history of the cholestasis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000001380","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T04:05:33Z","timestamp":1719979533000},"page":"524-536","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":17,"title":["What's new in pediatric genetic cholestatic liver disease: advances in etiology, diagnostics and therapeutic approaches"],"prefix":"10.1097","volume":"36","author":[{"given":"Michele","family":"Pinon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binita M.","family":"Kamath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,6,13]]},"reference":[{"key":"R1-20250730","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/hep.32437","article-title":"Cholestatic liver diseases of genetic etiology: advances and controversies","volume":"75","author":"Ibrahim","year":"2022","journal-title":"Hepatology"},{"key":"R2-20250730","doi-asserted-by":"crossref","first-page":"100782","DOI":"10.1016\/j.jhepr.2023.100782","article-title":"Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis","volume":"5","author":"Thompson","year":"2023","journal-title":"JHEP Rep"},{"key":"R3-20250730","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S2468-1253(22)00093-0","article-title":"Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial","volume":"7","author":"Thompson","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R4-20250730","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/S0140-6736(21)01256-3","article-title":"Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study","volume":"398","author":"Gonzales","year":"2021","journal-title":"Lancet"},{"key":"R5-20250730","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1002\/hep4.1980","article-title":"Maralixibat for the treatment of PFIC: Long-term, IBAT inhibition in an open-label, Phase 2 study","volume":"6","author":"Loomes","year":"2022","journal-title":"Hepatol Commun"},{"issue":"(S1)","key":"R6-20250730","first-page":"61","article-title":"Maralixibat leads to significant reductions in pruritus and improvements in sleep for children with progressive familial intrahepatic cholestasis: data from MARCH-PFIC","volume":"78","author":"Thompson","year":"2023","journal-title":"J Hepatol"},{"key":"R7-20250730","article-title":"Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trial","volume":"23","author":"Ovchinsky","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R8-20250730","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/MPG.0000000000001334","article-title":"Guideline for the evaluation of cholestatic jaundice in infants: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition","volume":"64","author":"Fawaz","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R9-20250730","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/hep.29516","article-title":"Organic solute transporter-\u03b2 (SLC51B) deficiency in two brothers with congenital diarrhea and features of cholestasis","volume":"68","author":"Sultan","year":"2018","journal-title":"Hepatology"},{"key":"R10-20250730","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1002\/hep.31087","article-title":"Organic solute transporter alpha deficiency: a disorder with cholestasis, liver fibrosis, and congenital diarrhea","volume":"71","author":"Gao","year":"2020","journal-title":"Hepatology"},{"key":"R11-20250730","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/cld.872","article-title":"Inherited cholestatic diseases in the era of personalized medicine","volume":"15","author":"Goldberg","year":"2020","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"R13-20250730","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1038\/s41390-021-01583-7","article-title":"Neonatal Dubin-Johnson syndrome: biochemical parameters, characteristics, and genetic variants study","volume":"91","author":"Fu","year":"2022","journal-title":"Pediatr Res"},{"key":"R14-20250730","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/MPG.0b013e3182169433","article-title":"Neonatal ichthyosis and sclerosing cholangitis syndrome: extremely variable liver disease severity from claudin-1 deficiency","volume":"53","author":"Paganelli","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R15-20250730","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1172\/JCI59526","article-title":"Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver","volume":"122","author":"Van De Steeg","year":"2012","journal-title":"J Clin Invest"},{"key":"R16-20250730","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.21037\/tp-20-360","article-title":"Clinical features of sodium-taurocholate cotransporting polypeptide deficiency in pediatric patients: case series and literature review","volume":"10","author":"Zou","year":"2021","journal-title":"Transl Pediatr"},{"key":"R17-20250730","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/ng.2918","article-title":"Mutations in TJP2 cause progressive cholestatic liver disease","volume":"46","author":"Sambrotta","year":"2014","journal-title":"Nat Genet"},{"key":"R18-20250730","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/s41436-018-0288-x","article-title":"Identification of novel loci for pediatric cholestatic liver disease defined by KIF12, PPM1F, USP53, LSR, and WDR83OS pathogenic variants","volume":"21","author":"Maddirevula","year":"2019","journal-title":"Genet Med"},{"key":"R19-20250730","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/ng1325","article-title":"Mutations in VPS33B, encoding a regulator of SNARE-dependent membrane fusion, cause arthrogryposis-renal dysfunction-cholestasis (ARC) syndrome","volume":"36","author":"Gissen","year":"2004","journal-title":"Nat Genet"},{"key":"R20-20250730","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm10030481","article-title":"Congenital diarrhea and cholestatic liver disease: phenotypic spectrum associated with MYO5B mutations","volume":"10","author":"Aldrian","year":"2021","journal-title":"J Clin Med"},{"key":"R21-20250730","doi-asserted-by":"crossref","first-page":"10713","DOI":"10.1038\/ncomms10713","article-title":"Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis","volume":"7","author":"Gomez-Ospina","year":"2016","journal-title":"Nat Commun;"},{"key":"R22-20250730","doi-asserted-by":"crossref","first-page":"E907","DOI":"10.3390\/diagnostics10110907","article-title":"Alagille syndrome: diagnostic challenges and advances in management","volume":"10","author":"Ayoub","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"R23-20250730","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.1097\/MPG.0000000000002517","article-title":"Homozygous NEK8 mutations in siblings with neonatal cholestasis progressing to end-stage liver, renal, and cardiac disease","volume":"70","author":"Hassan","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R24-20250730","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1399-3046.2005.00342.x","article-title":"Liver disease in autosomal recessive polycystic kidney disease","volume":"9","author":"Shneider","year":"2005","journal-title":"Pediatr Transplant"},{"key":"R25-20250730","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3390\/cells12020307","article-title":"The landscape of HNF1B deficiency: a syndrome not yet fully explored","volume":"12","author":"Gambella","year":"2023","journal-title":"Cells"},{"key":"R26-20250730","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/humu.23031","article-title":"DCDC2 mutations cause neonatal sclerosing cholangitis","volume":"37","author":"Girard","year":"2016","journal-title":"Hum Mutat"},{"key":"R27-20250730","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13023-021-01775-8","article-title":"A ZFYVE19 gene mutation associated with neonatal cholestasis and cilia dysfunction: case report with a novel pathogenic variant","volume":"16","author":"Mandato","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"R28-20250730","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/jmedgenet-2019-106706","article-title":"Biallelic loss-of-function ZFYVE19 mutations are associated with congenital hepatic fibrosis, sclerosing cholangiopathy and high-GGT cholestasis","volume":"58","author":"Luan","year":"2021","journal-title":"J Med Genet"},{"key":"R29-20250730","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1002\/hep.30982","article-title":"Biallelic mutations in tetratricopeptide repeat domain 26 (intraflagellar transport 56) cause severe biliary ciliopathy in humans","volume":"71","author":"Shaheen","year":"2020","journal-title":"Hepatology"},{"key":"R30-20250730","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1002\/hep.26512","article-title":"Extrahepatic anomalies in infants with biliary atresia: results of a large prospective North American multicenter study","volume":"58","author":"Schwarz","year":"2013","journal-title":"Hepatology"},{"key":"R31-20250730","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/adc.75.1.67","article-title":"Neonatal cholestasis as the presenting feature in cystic fibrosis","volume":"75","author":"Lykavieris","year":"1996","journal-title":"Arch Dis Child"},{"key":"R32-20250730","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1053\/j.gastro.2021.03.026","article-title":"Deleterious variants in ABCC12 are detected in idiopathic chronic cholestasis and cause intrahepatic bile duct loss in model organisms","volume":"161","author":"Pham","year":"2021","journal-title":"Gastroenterology"},{"key":"R33-20250730","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/304230a0","article-title":"Alpha 1-antitrypsin deficiency detection by direct analysis of the mutation in the gene","volume":"304","author":"Kidd","year":"1983","journal-title":"Nature"},{"key":"R34-20250730","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/jimd.12633","article-title":"Hepatic presentations of mitochondrial DNA depletion syndrome in children: a single tertiary liver centre experience","volume":"46","author":"Vara","year":"2023","journal-title":"J Inherit Metab Dis"},{"key":"R35-20250730","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/hep4.1824","article-title":"Liver disease and risk of hepatocellular carcinoma in children with mutations in TALDO1","volume":"6","author":"Grammatikopoulos","year":"2022","journal-title":"Hepatol Commun"},{"key":"R36-20250730","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1053\/j.gastro.2013.02.004","article-title":"Genetic defects in bile acid conjugation cause fat-soluble vitamin deficiency","volume":"144","author":"Setchell","year":"2013","journal-title":"Gastroenterology"},{"key":"R37-20250730","first-page":"3322","article-title":"Diagnosis in bile acid-CoA: amino acid N-acyltransferase deficiency","volume":"18","author":"Had\u017ei\u0107","year":"2012","journal-title":"World J Gastroenterol"},{"key":"R38-20250730","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.cld.2018.06.006","article-title":"Inborn errors of bile acid metabolism","volume":"22","author":"Heubi","year":"2018","journal-title":"Clin Liver Dis"},{"key":"R39-20250730","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.bpg.2010.07.010","article-title":"Familial cholestasis: progressive familial intrahepatic cholestasis, benign recurrent intrahepatic cholestasis and intrahepatic cholestasis of pregnancy","volume":"24","author":"Van Der Woerd","year":"2010","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R40-20250730","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1053\/j.gastro.2011.07.042","article-title":"Complementary functions of the flippase ATP8B1 and the floppase ABCB4 in maintaining canalicular membrane integrity","volume":"141","author":"Groen","year":"2011","journal-title":"Gastroenterology"},{"key":"R41-20250730","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1001\/archpedi.1969.02100030114014","article-title":"Byler disease. Fatal familial intrahepatic cholestasis in an Amish kindred","volume":"117","author":"Clayton","year":"1969","journal-title":"Am J Dis Child"},{"key":"R42-20250730","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1086\/515501","article-title":"Identification of a locus for progressive familial intrahepatic cholestasis PFIC2 on chromosome 2q24","volume":"61","author":"Strautnieks","year":"1997","journal-title":"Am J Hum Genet"},{"key":"R43-20250730","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1053\/j.gastro.2004.02.042","article-title":"ABCB4 gene mutations and primary sclerosing cholangitis [6\u25aa\u25aa] (multiple letters)","volume":"126","author":"Rosmorduc","year":"2004","journal-title":"Gastroenterology"},{"key":"R44-20250730","doi-asserted-by":"crossref","first-page":"100201","DOI":"10.1016\/j.jhepr.2020.100201","article-title":"Low-phospholipid-associated cholelithiasis syndrome: Prevalence, clinical features, and comorbidities","volume":"3","author":"Dong","year":"2020","journal-title":"JHEP Rep"},{"key":"R45-20250730","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/hep4.1149","article-title":"Phenotypic spectrum and diagnostic pitfalls of ABCB4 deficiency depending on age of onset","volume":"2","author":"Schatz","year":"2018","journal-title":"Hepatol Commun"},{"key":"R46-20250730","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jhep.2020.04.036","article-title":"Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults","volume":"73","author":"St\u00e4ttermayer","year":"2020","journal-title":"J Hepatol"},{"key":"R47-20250730","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00535-015-1110-z","article-title":"ABCB4 mutations in adult patients with cholestatic liver disease: impact and phenotypic expression","volume":"51","author":"Degiorgio","year":"2016","journal-title":"J Gastroenterol"},{"key":"R48-20250730","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1053\/j.gastro.2004.07.022","article-title":"Claudin-1 gene mutations in neonatal sclerosing cholangitis associated with ichthyosis: a tight junction disease","volume":"127","author":"Hadj-Rabia","year":"2004","journal-title":"Gastroenterology"},{"key":"R49-20250730","first-page":"362","article-title":"Severe congenital anomalies requiring transplantation in children with Kabuki syndrome","volume":"80","author":"Ewart-Toland","year":"1998","journal-title":"J Med Genet"},{"key":"R50-20250730","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/01.mpg.0000228114.06488.ef","article-title":"A child with Kabuki syndrome and primary sclerosing cholangitis successfully treated with ursodiol and cholestryamine","volume":"43","author":"Suskind","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R51-20250730","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1097\/HEP.0000000000000646","article-title":"Cystic fibrosis screening, evaluation and management of hepatobiliary disease consensus recommendations","volume":"79","author":"Sellers","year":"2024","journal-title":"Hepatology"},{"key":"R52-20250730","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ajhg.2020.11.013","article-title":"A dyadic approach to the delineation of diagnostic entities in clinical genomics","volume":"108","author":"Biesecker","year":"2021","journal-title":"Am J Hum Genet"},{"key":"R53-20250730","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/MPG.0000000000002926","article-title":"Cholestasis due to USP53 deficiency","volume":"72","author":"Bull","year":"2021","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R54-20250730","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/liv.15104","article-title":"MYO5B-associated diseases: novel liver-related variants and genotype\u2013phenotype correlation","volume":"42","author":"Wang","year":"2022","journal-title":"Liver Int"},{"key":"R55-20250730","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jhep.2019.01.036","article-title":"Clinical utility of genomic analysis in adults with idiopathic liver disease","volume":"70","author":"Hakim","year":"2019","journal-title":"J Hepatol"},{"key":"R56-20250730","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1002\/hep4.2051","article-title":"Clinical phenotype of adult-onset liver disease in patients with variants in ABCB4, ABCB11, and ATP8B1","volume":"6","author":"Nayagam","year":"2022","journal-title":"Hepatol Commun"},{"key":"R57-20250730","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.dld.2020.12.003","article-title":"ABCB4 variants in adult patients with cholestatic disease are frequent and underdiagnosed","volume":"53","author":"Avena","year":"2021","journal-title":"Dig Liver Dis"},{"key":"R58-20250730","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1111\/liv.14662","article-title":"Carriers of ABCB4 gene variants show a mild clinical course, but impaired quality of life and limited risk for cholangiocarcinoma","volume":"40","author":"de Vries","year":"2020","journal-title":"Liver Int"},{"key":"R59-20250730","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1056\/NEJMra1010172","article-title":"Ciliopathies","volume":"364","author":"Hildebrandt","year":"2011","journal-title":"N Engl J Med"},{"key":"R60-20250730","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13052-019-0617-y","article-title":"Not only Alagille syndrome syndromic paucity of interlobular bile ducts secondary to HNF1\u03b1 deficiency: a case report and literature review","volume":"45","author":"Pinon","year":"2019","journal-title":"Ital J Pediatr"},{"key":"R61-20250730","doi-asserted-by":"crossref","first-page":"e001013","DOI":"10.1136\/bmjgast-2022-001013","article-title":"New case of syncytial giant-cell variant of hepatocellular carcinoma in a pediatric patient with HNF1B deficiency: does it fit with the syndrome?","volume":"9","author":"Pinon","year":"2022","journal-title":"BMJ Open Gastroenterol"},{"key":"R62-20250730","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1097\/MPG.0000000000002015","article-title":"Hepatocarcinoma and cholestasis associated to germline hemizygous deletion of gene HNF1B","volume":"68","author":"De Leusse","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R63-20250730","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.3390\/cancers14143421","article-title":"Genetics in familial intrahepatic cholestasis: clinical patterns and development of liver and biliary cancers: a review of the literature","volume":"14","author":"Vitale","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R64-20250730","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13052-019-0679-x","article-title":"Cholestatic jaundice in infancy: struggling with many old and new phenotypes","volume":"45","author":"Mandato","year":"2019","journal-title":"Ital J Pediatr"},{"key":"R65-20250730","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1681\/ASN.2004121083","article-title":"Kinesin family member 12 is a candidate polycystic kidney disease modifier in the cpk mouse","volume":"16","author":"Mrug","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R66-20250730","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jpeds.2021.09.019","article-title":"KIF12 variants and disturbed hepatocyte polarity in children with a phenotypic spectrum of cholestatic liver disease","volume":"240","author":"Stalke","year":"2022","journal-title":"J Pediatr"},{"key":"R67-20250730","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1681\/ASN.2008020238","article-title":"HNF-1beta regulates transcription of the PKD modifier gene Kif12","volume":"20","author":"Gong","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R68-20250730","doi-asserted-by":"crossref","first-page":"dmm049326","DOI":"10.1242\/dmm.049326","article-title":"Loss of zebrafish pkd1l1 causes biliary defects that have implications for biliary atresia splenic malformation","volume":"16","author":"Ali","year":"2023","journal-title":"DMM Dis Models Mech"},{"key":"R69-20250730","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/hep.30515","article-title":"Identification of PKD1L1 gene variants in children with the biliary atresia splenic malformation syndrome","volume":"70","author":"Berauer","year":"2019","journal-title":"Hepatology"},{"key":"R70-20250730","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1055\/a-2153-8927","article-title":"Genetic contributions to biliary atresia: a developmental cholangiopathy","volume":"43","author":"Hellen","year":"2023","journal-title":"Semin Liver Dis"},{"key":"R71-20250730","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jhep.2023.07.039","article-title":"Biliary atresia is associated with polygenic susceptibility in ciliogenesis and planar polarity effector genes","volume":"79","author":"Glessner","year":"2023","journal-title":"J Hepatol"},{"key":"R72-20250730","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1097\/HEP.0000000000000029","article-title":"Liver-restricted deletion of the biliary atresia candidate gene Pkd1l1 causes bile duct dysmorphogenesis and ciliopathy","volume":"77","author":"Hellen","year":"2023","journal-title":"Hepatology"},{"key":"R73-20250730","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/MPG.0000000000003094","article-title":"Use of a comprehensive 66-gene cholestasis sequencing panel in 2171 cholestatic infants, children, and young adults","volume":"72","author":"Karpen","year":"2021","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R74-20250730","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.cgh.2011.01.003","article-title":"Design and validation of the Biliary Atresia Research Consortium histological assessment system for cholestasis in infancy","volume":"9","author":"Russo","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R75-20250730","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jpeds.2019.04.016","article-title":"Diagnostic yield of an algorithm for neonatal and infantile cholestasis integrating next-generation sequencing","volume":"211","author":"Nicastro","year":"2019","journal-title":"J Pediatr"},{"key":"R76-20250730","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3389\/fped.2020.00373","article-title":"Genomic diagnosis for pediatric disorders: revolution and evolution","volume":"8","author":"Lalonde","year":"2020","journal-title":"Front Pediatr"},{"key":"R77-20250730","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1097\/PAS.0000000000000755","article-title":"Key histopathologic features of liver biopsies that distinguish biliary atresia from other causes of infantile cholestasis and their correlation with outcome: a multicenter study","volume":"40","author":"Russo","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R78-20250730","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/PAS.0b013e318212ec87","article-title":"Morphologic findings in progressive familial intrahepatic cholestasis 2 (PFIC2): correlation with genetic and immunohistochemical studies","volume":"35","author":"Evason","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R79-20250730","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s12098-017-2408-z","article-title":"Role of hepatobiliary scintigraphy and preoperative liver biopsy for exclusion of biliary atresia in neonatal cholestasis syndrome","volume":"84","author":"Mandelia","year":"2017","journal-title":"Indian J Pediatr"},{"key":"R80-20250730","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jpedsurg.2016.02.016","article-title":"The value of preoperative liver biopsy in the diagnosis of extrahepatic biliary atresia: a systematic review and meta-analysis","volume":"51","author":"Lee","year":"2016","journal-title":"J Pediatr Surg"},{"key":"R81-20250730","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.cgh.2011.01.003","article-title":"Design and validation of the biliary atresia research consortium histologic assessment system for cholestasis in infancy","volume":"9","author":"Russo","year":"2011","journal-title":"Clin Gastroenterol Hepatol;"},{"key":"R82-20250730","first-page":"134","article-title":"Clinical and biochemical findings in progressive familial intrahepatic cholestasis","volume":"18","author":"Whitington","year":"1994","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R83-20250730","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/S2210-7401(12)70018-9","article-title":"Progressive familial intrahepatic cholestasis","volume":"36","author":"Jacquemin","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R84-20250730","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jhep.2020.02.007","article-title":"Genotype correlates with the natural history of severe bile salt export pump deficiency","volume":"73","author":"van Wessel","year":"2020","journal-title":"J Hepatol"},{"key":"R85-20250730","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/hep.31787","article-title":"Impact of genotype, serum bile acids, and surgical biliary diversion on native liver survival in FIC1 deficiency","volume":"74","author":"van Wessel","year":"2021","journal-title":"Hepatology"},{"key":"R86-20250730","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/hep.32761","article-title":"Natural history of liver disease in a large international cohort of children with Alagille syndrome: results from the GALA study","volume":"77","author":"Vandriel","year":"2023","journal-title":"Hepatology"},{"key":"R87-20250730","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1590-8658(02)80033-0","article-title":"Bile acid-mediated hepatocyte apoptosis and cholestatic liver disease","volume":"34","author":"Guicciardi","year":"2002","journal-title":"Dig Liver Dis"},{"key":"R88-20250730","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jhep.2015.02.023","article-title":"New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond","volume":"62","author":"Beuers","year":"2015","journal-title":"J Hepatol"},{"key":"R89-20250730","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1053\/gast.2001.23984","article-title":"The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood","volume":"120","author":"Jacquemin","year":"2001","journal-title":"Gastroenterology"},{"key":"R90-20250730","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/MPG.0b013e318297e384","article-title":"Management of cholestatic pruritus in paediatric patients with alagille syndrome: the King's College Hospital experience","volume":"57","author":"Kronsten","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R91-20250730","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1136\/gutjnl-2017-314553","article-title":"Colesevelam attenuates cholestatic liver and bile duct injury in Mdr2\u2212\/\u2212 mice by modulating composition, signalling and excretion of faecal bile acids","volume":"67","author":"Fuchs","year":"2018","journal-title":"Gut"},{"key":"R92-20250730","first-page":"442","article-title":"Use of rifampin for severe pruritus in children with chronic cholestasis","volume":"29","author":"Yerushalmi","year":"1999","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R93-20250730","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/MPG.0000000000001385","article-title":"Sertraline as an additional treatment for cholestatic pruritus in children","volume":"64","author":"Th\u00e9baut","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R94-20250730","doi-asserted-by":"crossref","first-page":"S965","DOI":"10.1016\/S0168-8278(23)03017-9","article-title":"Efficacy and safety outcomes with odevixibat treatment: pooled data from the phase 3 ASSERT and ASSERT-EXT studies in patients with Alagille syndrome","volume":"78","author":"Ovchinsky","year":"2023","journal-title":"J Hepatol"},{"key":"R95-20250730","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3748\/wjg.v12.i7.1125","article-title":"Effect of oral naltrexone on pruritus in cholestatic patients","volume":"12","author":"Mansour-Ghanaei","year":"2006","journal-title":"World J Gastroenterol"},{"key":"R96-20250730","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/00042737-199810000-00010","article-title":"Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trial","volume":"10","author":"M\u00fcller","year":"1998","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R97-20250730","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1055\/s-2003-43570","article-title":"Surgical treatment of progressive familial intrahepatic cholestasis: comparison of partial external biliary diversion and ileal bypass","volume":"13","author":"Kalici\u0144ski","year":"2003","journal-title":"Eur J Pediatr Surg"},{"key":"R98-20250730","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jpedsurg.2016.11.021","article-title":"Outcomes following partial external biliary diversion in patients with progressive familial intrahepatic cholestasis","volume":"52","author":"Lemoine","year":"2017","journal-title":"J Pediatr Surg"},{"key":"R99-20250730","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3390\/children9050669","article-title":"Ileal bile acid transporter inhibition reduces post-transplant diarrhea and growth failure in FIC1 disease\u2014a case report","volume":"9","author":"Ohlendorf","year":"2022","journal-title":"Children"},{"key":"R100-20250730","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/MPG.0000000000002200","article-title":"Alloimmunity and cholestasis after liver transplantation in children with progressive familial intrahepatic cholestasis","volume":"68","author":"Krebs-Schmitt","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R101-20250730","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s13023-018-0920-5","article-title":"Cholic acid for primary bile acid synthesis defects: a life-saving therapy allowing a favorable outcome in adulthood","volume":"13","author":"Gonzales","year":"2018","journal-title":"Orphanet J Rare Dis;"},{"key":"R102-20250730","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1001\/jama.2023.8120","article-title":"Cystic fibrosis: a review","volume":"329","author":"Ong","year":"2023","journal-title":"JAMA"},{"key":"R103-20250730","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/hep.28991","article-title":"New therapeutic concepts in bile acid transport and signaling for management of cholestasis","volume":"65","author":"Trauner","year":"2017","journal-title":"Hepatology"},{"key":"R104-20250730","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/MPG.0000000000002443","article-title":"Nutrition support of children with chronic liver diseases","volume":"69","author":"Mouzaki","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R105-20250730","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.cld.2022.03.011","article-title":"Fat soluble vitamin assessment and supplementation in cholestasis","volume":"26","author":"Kamath","year":"2022","journal-title":"Clin Liver Dis"},{"key":"R106-20250730","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1750-1172-2-29","article-title":"Low phospholipid associated cholelithiasis: association with mutation in the MDR3\/ABCB4 gene","volume":"2","author":"Rosmorduc","year":"2007","journal-title":"Orphanet J Rare Dis;"},{"key":"R107-20250730","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1111\/liv.14553","article-title":"Potential of ileal bile acid transporter inhibition as a therapeutic target in Alagille syndrome and progressive familial intrahepatic cholestasis","volume":"40","author":"Kamath","year":"2020","journal-title":"Liver Int"},{"key":"R108-20250730","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1002\/hep4.1992","article-title":"Impact of long-term administration of maralixibat on children with cholestasis secondary to Alagille syndrome","volume":"6","author":"Shneider","year":"2022","journal-title":"Hepatol Commun"},{"key":"R109-20250730","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jpeds.2022.09.001","article-title":"Maralixibat treatment response in Alagille syndrome is associated with improved health-related quality of life","volume":"252","author":"Kamath","year":"2023","journal-title":"J Pediatr"},{"key":"R110-20250730","doi-asserted-by":"crossref","first-page":"100949","DOI":"10.1016\/j.jhepr.2023.100949","article-title":"Opinion paper on the diagnosis and treatment of progressive familial intrahepatic cholestasis","volume":"6","author":"McKiernan","year":"2024","journal-title":"JHEP Rep"},{"key":"R111-20250730","first-page":"1279","article-title":"Event-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALA","volume":"76","author":"Hansen","year":"2023","journal-title":"Hepatology"},{"key":"R112-20250730","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1097\/HEP.0000000000000502","article-title":"Predictors of 6-year event-free survival in Alagille syndrome patients treated with maralixibat, an ileal bile acid transporter inhibitor","volume":"78","author":"Sokol","year":"2023","journal-title":"Hepatology"},{"key":"R113-20250730","doi-asserted-by":"crossref","first-page":"S969","DOI":"10.1016\/S0168-8278(23)03022-2","article-title":"Analysis of long-term treatment effects of odevixibat on clinical outcomes in children with progressive familial intrahepatic cholestasis in odevixibat clinical studies vs external controls from the NAPPED database","volume":"78","author":"Hansen","year":"2023","journal-title":"J Hepatol"},{"key":"R114-20250730","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.cgh.2022.10.032","article-title":"GLIMMER: a randomized phase 2b dose-ranging trial of linerixibat in primary biliary cholangitis patients with pruritus","volume":"21","author":"Levy","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R115-20250730","doi-asserted-by":"crossref","first-page":"e0153","DOI":"10.1097\/HC9.0000000000000153","article-title":"Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: open-label pilot study","volume":"7","author":"Bowlus","year":"2023","journal-title":"Hepatol Commun"},{"key":"R116-20250730","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/HEP.0000000000000376","article-title":"A3907, a systemic ASBT inhibitor, improves cholestasis in mice by multiorgan activity and shows translational relevance to humans","volume":"78","author":"Caballero-Camino","year":"2023","journal-title":"Hepatology"},{"key":"R117-20250730","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/HEP.0000000000000473","article-title":"Choluresis?","volume":"78","author":"Thompson","year":"2023","journal-title":"Hepatology"},{"key":"R118-20250730","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jhep.2023.10.035","article-title":"Inhibition of the renal apical sodium dependent bile acid transporter prevents cholemic nephropathy in mice with obstructive cholestasis","volume":"80","author":"Ghallab","year":"2024","journal-title":"J Hepatol;"},{"key":"R119-20250730","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1016\/j.jhep.2023.02.006","article-title":"Effects of CFTR modulator therapies on liver stiffness and bile flow: a single-centre experience","volume":"79","author":"Calvo","year":"2023","journal-title":"J Hepatol"},{"key":"R120-20250730","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/hep.23810","article-title":"The biliary HCO(3)(\u2212) umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies","volume":"52","author":"Beuers","year":"2010","journal-title":"Hepatology"},{"key":"R121-20250730","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/liv.14839","article-title":"Effect of CFTR correctors on the traffic and the function of intracellularly retained ABCB4 variants","volume":"41","author":"Ben Saad","year":"2021","journal-title":"Liver Int"},{"key":"R122-20250730","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/hep.27767","article-title":"Targeted pharmacotherapy in progressive familial intrahepatic cholestasis type 2: evidence for improvement of cholestasis with 4-phenylbutyrate","volume":"62","author":"Gonzales","year":"2015","journal-title":"Hepatology"},{"key":"R123-20250730","doi-asserted-by":"crossref","first-page":"10758","DOI":"10.3390\/ijms231810758","article-title":"In vitro rescue of the bile acid transport function of ABCB11 variants by CFTR potentiators","volume":"23","author":"Mareux","year":"2022","journal-title":"Int J Mol Sci;"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001380","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T18:01:04Z","timestamp":1753898464000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,13]]},"references-count":122,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000001380","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,13]]}}}